FDA issues 5 citations to Meridian Trading Company in Boulder following Feb. 2 inspection

Sridhar Mantha, Acting Chief Information Officer of FDA
Sridhar Mantha, Acting Chief Information Officer of FDA
0Comments

During a Feb. 2 inspection at Meridian Trading Company in Boulder, the Food and Drug Administration (FDA) cited the company for 5 issues related to foodborne biological hazards, according to information published on the FDA’s website.

The FDA website details the following citations issued to the company:

  • ‘Your hazard analysis did not identify a hazard that requires a control.’
  • ‘You did not document that you approved a foreign supplier based on an evaluation that you conducted of the foreign supplier’s performance and the risk posed by a food or based on a review and assessment of another entity’s evaluation of a foreign supplier’s performance and the risk posed by a food.’
  • ‘You did not establish written procedures to ensure that you import foods only from approved foreign suppliers.’
  • ‘Your verification activity did not address the entity that is significantly minimizing or preventing the hazards or verifying that the hazards have been significantly minimized or prevented.’
  • ‘For a food that may contain a hazard that will be controlled by the foreign supplier and is one for which there is a reasonable probability that exposure to the hazard will result in serious adverse health consequences or death to humans or animals, you did not conduct and document or obtain documentation of an onsite audit of the foreign supplier.’

The FDA conducts periodic inspections nationwide to assess whether facilities and their products comply with FDA laws and regulations that aim to enhance public health. Results of these inspections are made publicly available.

The agency’s website states the FDA is a government agency chiefly tasked with overseeing the safety and quality of human and animal drugs, biological products, medical supplies, and tobacco products.

Information for this article was provided by the U.S. Food and Drug Administration. The original data is available here.



Related

Caleb Michaud, Acting Associate Commissioner for External Affairs of FDA

FDA inspects Silver Canyon Coffee in Boulder for compliance on April 22

FDA records note an inspection at Silver Canyon Coffee in Boulder conducted on April 22, focusing on food composition, standards, labeling, economics, and biological hazards associated with foodborne illnesses.

Jim Traficant, Chief of Staff of FDA

FDA cites Silver Canyon Coffee in Boulder during April 22 inspection

The Food and Drug Administration conducted an inspection of Silver Canyon Coffee in Boulder on April 22, citing the business once for plant maintenance issues and reviewing food standards, labeling and biological hazards, based on information from the FDA’s official website.

Dr. Mehmet Oz CMS Administrator

Alcohol and drug abuse treatment Medicaid spending in Boulder surges to nearly $500,000 in 2024

Boulder saw Medicaid spending for Alcohol and Drug Abuse Treatment services jump by 91.7% to $499,954 in 2024, highlighting changing service use and payment trends in the city.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Boulder Leader.